
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Certara has announced the launch of Phoenix 8.2, pharmacokinetic/pharmacodynamic modeling and simulation software for drug development that supports electronic data, methods and results audit, traceability and communication requirements.
For more on the newest version, click






